Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
83 studies found for:    DIAS-4
Show Display Options
Rank Status Study
1 Terminated Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
Condition: Stroke
Interventions: Drug: Desmoteplase;   Drug: Placebo
2 Completed Protection Against Benzene Toxicity
Conditions: Leukemia;   Aplastic Anemia
Intervention:
3 Completed
Has Results
Diabetes Assistant (DiAs) Control-to-Range (CTR) Nocturnal Closed-Loop Camp Study
Condition: Diabetes Mellitus, Type 1
Interventions: Device: Diabetes Assistant (DiAs);   Device: Tandem t:slim Insulin Pump;   Device: Dexcom G4 Platinum sensor
4 Completed Desmoteplase in Acute Ischemic Stroke (DIAS)
Condition: Stroke
Interventions: Drug: Desmoteplase;   Drug: Placebo
5 Completed
Has Results
Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children
Conditions: Eyelash Hypotrichosis;   Alopecia Areata
Interventions: Drug: bimatoprost ophthalmic solution 0.03%;   Drug: Vehicle Sterile Solution
6 Completed Bimatoprost in the Treatment of Eyelash Hypotrichosis
Condition: Idiopathic Eyelash Hypotrichosis
Interventions: Drug: bimatoprost formulation A solution;   Drug: bimatoprost solution 0.03 %;   Drug: vehicle of bimatoprost formulation A solution;   Drug: vehicle of bimatoprost solution 0.03 %
7 Completed
Has Results
Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis
Condition: Eyelash Hypotrichosis
Interventions: Drug: bimatoprost solution 0.03%;   Drug: bimatoprost vehicle solution
8 Completed
Has Results
Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis
Condition: Eyelash Hypotrichosis
Interventions: Drug: bimatoprost solution 0.03%;   Drug: bimatoprost vehicle solution
9 Unknown  Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia
Condition: Type 2 Diabetes
Interventions: Drug: Glimepiride;   Drug: glyburide;   Other: glucose clamp
10 Completed
Has Results
Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects
Condition: HIV Infections
Intervention: Drug: Tipranavir
11 Recruiting Metformin vs Conjugated Linoleic Acid and an Intervention Program With Healthy Habits in Obese Children
Condition: Obesity
Interventions: Drug: metformin;   Dietary Supplement: Conjugated Linoleic Acid;   Drug: Placebo;   Behavioral: Healthy habits program
12 Active, not recruiting Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes (Italy)
Condition: Type 1 Diabetes Mellitus
Intervention: Device: Closed Loop Control with the Advisory/Automated Adaptive (AAA) Control system
13 Completed
Has Results
The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo;   Drug: Canagliflozin;   Drug: Sitagliptin;   Drug: Metformin immediate release
14 Recruiting Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Canagliflozin, 100 mg;   Drug: Canagliflozin, 300 mg;   Drug: Placebo
15 Completed A Study to Compare the Pharmacodynamics of Canagliflozin and Dapagliflozin in Healthy Volunteers
Condition: Healthy
Interventions: Drug: Canagliflozin;   Drug: Dapagliflozin
16 Unknown  Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
Condition: Leukemia
Interventions: Biological: filgrastim;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: etoposide;   Drug: idarubicin;   Drug: mesna;   Drug: mitoxantrone hydrochloride;   Procedure: allogeneic bone marrow transplantation;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
17 Completed Bioequivalence Study of Metformin Component of Canagliflozin and Metformin Fixed Dose Combination Immediate Release (IR) Tablet Comparing With Metformin IR Tablet Co-administered With Canagliflozin Tablet in Healthy Fed and Fasted Participants
Condition: Healthy
Interventions: Drug: Canagliflozin + Metformin Immediate Release (IR) Fixed Dose Combination (FDC);   Drug: Canagliflozin;   Drug: Metformin IR
18 Terminated Influence of Atorvastatin on Viral Replication During Antiretroviral Treatment Interruption
Condition: HIV Infections
Intervention: Drug: Atorvastatin 40 mg/Atorvastatin 80 mg
19 Active, not recruiting Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
Condition: Epilepsy
Interventions: Drug: perampanel;   Drug: Placebo
20 Terminated
Has Results
Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation
Condition: HIV Infections
Interventions: Drug: tipranavir;   Drug: ritonavir

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years